Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Tracking therapies in MS: More evidence in favor of neurofilament.

Yeh EA, Sormani MP.

Neurology. 2020 Feb 11. pii: 10.1212/WNL.0000000000009091. doi: 10.1212/WNL.0000000000009091. [Epub ahead of print] No abstract available.

PMID:
32047072
2.

Machine learning outperforms human experts in MRI pattern analysis of muscular dystrophies.

Morrow JM, Sormani MP.

Neurology. 2020 Feb 6. pii: 10.1212/WNL.0000000000009053. doi: 10.1212/WNL.0000000000009053. [Epub ahead of print] No abstract available.

PMID:
32029549
3.

An "all-wheel drive" proposal to accelerate clinical research in common and rare neurological diseases.

Salvetti M, Battaglia MA, Di Filippo M, Mancardi GL, Mancuso M, Patti F, Sormani MP, Zaratin P.

Neurol Sci. 2019 Dec 19. doi: 10.1007/s10072-019-04189-4. [Epub ahead of print] Review.

PMID:
31858329
4.

Predicting disability progression in multiple sclerosis: Insights from advanced statistical modeling.

Pellegrini F, Copetti M, Sormani MP, Bovis F, de Moor C, Debray TP, Kieseier BC.

Mult Scler. 2019 Nov 5:1352458519887343. doi: 10.1177/1352458519887343. [Epub ahead of print]

PMID:
31686590
5.

Measuring disability in multiple sclerosis: Walking plus much more.

Sormani MP, Naismith RT.

Neurology. 2019 Nov 19;93(21):919-920. doi: 10.1212/WNL.0000000000008515. Epub 2019 Oct 22. No abstract available.

PMID:
31641015
6.

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.

Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group.

Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4.

PMID:
31610404
7.

Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.

Tur C, Kalincik T, Oh J, Sormani MP, Tintoré M, Butzkueven H, Montalban X.

Neurology. 2019 Oct 29;93(18):793-809. doi: 10.1212/WNL.0000000000008319. Epub 2019 Oct 7. Review.

PMID:
31591277
8.

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.

Zecca C, Bovis F, Novi G, Capobianco M, Lanzillo R, Frau J, Repice AM, Hakiki B, Realmuto S, Bonavita S, Curti E, Brambilla L, Mataluni G, Cavalla P, Di Sapio A, Signoriello E, Barone S, Maniscalco GT, Maietta I, Maraffi I, Boffa G, Malucchi S, Nozzolillo A, Coghe G, Mechi C, Salemi G, Gallo A, Sacco R, Cellerino M, Malentacchi M, De Angelis M, Lorefice L, Magnani E, Prestipino E, Sperli F, Brescia Morra V, Fenu G, Barilaro A, Abbadessa G, Signori A, Granella F, Amato MP, Uccelli A, Gobbi C, Sormani MP.

Mult Scler. 2019 Oct 1:1352458519872889. doi: 10.1177/1352458519872889. [Epub ahead of print]

PMID:
31573386
9.

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).

Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K, Labopin M, Mancardi G, Martin R, Moore J, Muraro PA, Rovira M, Sormani MP, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE).

Bone Marrow Transplant. 2020 Feb;55(2):283-306. doi: 10.1038/s41409-019-0684-0. Epub 2019 Sep 26.

10.

Real-world studies provide reliable comparisons of disease modifying therapies in MS - No.

Sormani MP.

Mult Scler. 2020 Feb;26(2):161-162. doi: 10.1177/1352458519845837. Epub 2019 Sep 3. No abstract available.

PMID:
31478793
11.

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Clerico M, De Mercanti SF, Signori A, Iudicello M, Cordioli C, Signoriello E, Lus G, Bonavita S, Lavorgna L, Maniscalco GT, Curti E, Lorefice L, Cocco E, Nociti V, Mirabella M, Baroncini D, Mataluni G, Landi D, Petruzzo M, Lanzillo R, Gandoglia I, Laroni A, Frangiamore R, Sartori A, Cavalla P, Costantini G, Sormani MP, Capra R.

Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.

PMID:
31452081
12.

Severe Heterotopic Ossification in the Skeletal Muscle and Endothelial Cells Recruitment to Chondrogenesis Are Enhanced by Monocyte/Macrophage Depletion.

Tirone M, Giovenzana A, Vallone A, Zordan P, Sormani M, Nicolosi PA, Meneveri R, Gigliotti CR, Spinelli AE, Bocciardi R, Ravazzolo R, Cifola I, Brunelli S.

Front Immunol. 2019 Jul 19;10:1640. doi: 10.3389/fimmu.2019.01640. eCollection 2019.

13.

The role of nutritional factors during adolescence in multiple sclerosis onset: a population-based incident case-control study.

Abdollahpour I, Sormani MP, Nedjat S, Mansournia MA, van der Mei I.

Nutr Neurosci. 2019 Jul 31:1-8. doi: 10.1080/1028415X.2019.1647689. [Epub ahead of print]

PMID:
31362644
14.

Single-Port Versus Conventional Laparoscopic Cholecystectomy: Better Cosmesis at the Price of an Increased Incisional Hernia Rate?

Casaccia M, Papadia FS, Palombo D, Di Domenico S, Sormani MP, Batistotti P, Mascherini M, De Cian F.

J Laparoendosc Adv Surg Tech A. 2019 Sep;29(9):1163-1167. doi: 10.1089/lap.2019.0374. Epub 2019 Jul 2.

PMID:
31264921
15.

Blood neurofilament light as a potential endpoint in Phase 2 studies in MS.

Sormani MP, Haering DA, Kropshofer H, Leppert D, Kundu U, Barro C, Kappos L, Tomic D, Kuhle J.

Ann Clin Transl Neurol. 2019 May 28;6(6):1081-1089. doi: 10.1002/acn3.795. eCollection 2019 Jun.

16.

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study.

Frau J, Saccà F, Signori A, Baroncini D, Fenu G, Annovazzi P, Capobianco M, Signoriello E, Laroni A, La Gioia S, Sartori A, Maniscalco GT, Bonavita S, Clerico M, Russo CV, Gallo A, Lapucci C, Carotenuto A, Sormani MP, Cocco E; i-MuST study group.

J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.

PMID:
31209573
17.

Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data.

Bovis F, Carmisciano L, Signori A, Pardini M, Steinerman JR, Li T, Tansy AP, Sormani MP.

BMC Med. 2019 Jun 18;17(1):113. doi: 10.1186/s12916-019-1345-2.

18.

Lifespan normative data on rates of brain volume changes.

Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, Filippi M, Rocca MA, Preziosa P, Gallo A, Bisecco A, Palace J, Kong Y, Horakova D, Vaneckova M, Gasperini C, Ruggieri S, De Stefano N; MAGNIMS Study Group.

Neurobiol Aging. 2019 Sep;81:30-37. doi: 10.1016/j.neurobiolaging.2019.05.010. Epub 2019 May 22.

PMID:
31207467
19.

Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debate.

Scarpazza C, Signori A, Cosottini M, Sormani MP, Gerevini S, Capra R.

Mult Scler. 2019 May 30:1352458519854162. doi: 10.1177/1352458519854162. [Epub ahead of print]

PMID:
31144589
20.

A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis.

Pellegrini F, Copetti M, Bovis F, Cheng D, Hyde R, de Moor C, Kieseier BC, Sormani MP.

Mult Scler. 2019 May 30:1352458519849513. doi: 10.1177/1352458519849513. [Epub ahead of print]

PMID:
31144577
21.

Different MRI patterns in MS worsening after stopping fingolimod.

Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 16;6(4):e566. doi: 10.1212/NXI.0000000000000566. eCollection 2019 Jul.

22.

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.

Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS; MESEMS study group.

Trials. 2019 May 9;20(1):263. doi: 10.1186/s13063-019-3346-z.

23.

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.

Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T; IPMSSG.

Neurology. 2019 May 28;92(22):e2538-e2549. doi: 10.1212/WNL.0000000000007572. Epub 2019 May 1. Erratum in: Neurology. 2019 Oct 1;93(14):647.

24.

Predictors of hospital-based multidisciplinary rehabilitation effects in persons with multiple sclerosis: a large-scale, single-centre study.

Groppo E, Signori A, Sormani MP, Grosso C, Mantia L, Cattaneo D, Rovaris M.

Mult Scler J Exp Transl Clin. 2019 Apr 16;5(2):2055217319843673. doi: 10.1177/2055217319843673. eCollection 2019 Apr-Jun.

25.

Classification criteria for autoinflammatory recurrent fevers.

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. Review.

PMID:
31018962
26.

Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.

Treaba CA, Granberg TE, Sormani MP, Herranz E, Ouellette RA, Louapre C, Sloane JA, Kinkel RP, Mainero C.

Radiology. 2019 Jun;291(3):740-749. doi: 10.1148/radiol.2019181719. Epub 2019 Apr 9.

PMID:
30964421
27.

Multiple sclerosis: clinical trial design 2019.

Pardini M, Cutter G, Sormani MP.

Curr Opin Neurol. 2019 Jun;32(3):358-364. doi: 10.1097/WCO.0000000000000697.

PMID:
30950845
28.

Epidemiological features and risk factors for mortality in Pseudomonas aeruginosa bacteremia in children.

Rosanova MT, Mussini MS, Arias AP, Sormani MI, Mastroianni A, García ME, Reijtman V, Sarkis C.

Arch Argent Pediatr. 2019 Apr 1;117(2):128-131. doi: 10.5546/aap.2019.eng.128. English, Spanish.

29.

How much do periventricular lesions assist in distinguishing migraine with aura from CIS?

Lapucci C, Saitta L, Bommarito G, Sormani MP, Pardini M, Bonzano L, Mancardi GL, Gasperini C, Giorgio A, Inglese M, De Stefano N, Roccatagliata L.

Neurology. 2019 Apr 9;92(15):e1739-e1744. doi: 10.1212/WNL.0000000000007266. Epub 2019 Mar 8.

PMID:
30850445
30.

Laparoscopic Splenectomy Versus Open Splenectomy In Massive and Giant Spleens: Should we Update the 2008 EAES Guidelines?

Casaccia M, Sormani MP, Palombo D, Dellepiane C, Ibatici A.

Surg Laparosc Endosc Percutan Tech. 2019 Jun;29(3):178-181. doi: 10.1097/SLE.0000000000000637.

PMID:
30720696
31.

Revised upper limb module for spinal muscular atrophy: 12 month changes.

Pera MC, Coratti G, Mazzone ES, Montes J, Scoto M, De Sanctis R, Main M, Mayhew A, Muni Lofra R, Dunaway Young S, Glanzman AM, Duong T, Pasternak A, Ramsey D, Darras B, Day JW, Finkel RS, De Vivo DC, Sormani MP, Bovis F, Straub V, Muntoni F, Pane M, Mercuri E; iSMAC Consortium Group.

Muscle Nerve. 2019 Apr;59(4):426-430. doi: 10.1002/mus.26419. Epub 2019 Feb 7.

PMID:
30677148
32.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

33.

Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study.

Benedetti L, Briani C, Beronio A, Massa F, Giorli E, Sani C, Delia P, Artioli S, Sormani MP, Mannironi A, Tartaglione A, Mancardi GL.

J Peripher Nerv Syst. 2019 Mar;24(1):80-86. doi: 10.1111/jns.12292. Epub 2018 Dec 11.

PMID:
30421471
34.

Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution.

Scarpazza C, Signori A, Prosperini L, Sormani MP, Cosottini M, Capra R, Gerevini S; Italian PML Group.

J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):261-267. doi: 10.1136/jnnp-2018-319208. Epub 2018 Nov 2.

PMID:
30389778
35.

Learning ability correlates with brain atrophy and disability progression in RRMS.

Sormani MP, De Stefano N, Giovannoni G, Langdon D, Piani-Meier D, Haering DA, Kappos L, Tomic D.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):38-43. doi: 10.1136/jnnp-2018-319129. Epub 2018 Oct 15.

36.

A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).

Tagliafico AS, Mariscotti G, Valdora F, Durando M, Nori J, La Forgia D, Rosenberg I, Caumo F, Gandolfo N, Sormani MP, Signori A, Calabrese M, Houssami N.

Eur J Cancer. 2018 Nov;104:39-46. doi: 10.1016/j.ejca.2018.08.029. Epub 2018 Oct 11.

PMID:
30316869
37.

Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas.

Bovis F, Signori A, Carmisciano L, Maietta I, Steinerman JR, Li T, Tansy AP, Sormani MP.

Ann Neurol. 2018 Oct;84(4):621-625. doi: 10.1002/ana.25323. Epub 2018 Oct 4.

PMID:
30179270
38.

Neurofilaments as biomarkers in neurological disorders.

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J.

Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z. Review.

PMID:
30171200
39.

Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.

Bonzano L, Bove M, Sormani MP, Stromillo ML, Giorgio A, Amato MP, Tacchino A, Mancardi GL, De Stefano N.

Eur J Neurol. 2019 Jan;26(1):162-167. doi: 10.1111/ene.13789. Epub 2018 Sep 24. Erratum in: Eur J Neurol. 2019 May;26(5):830.

PMID:
30133054
40.

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Saccà F, Lanzillo R, Signori A, Maniscalco GT, Signoriello E, Lo Fermo S, Repice A, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Rossi S, Pareja Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Torri Clerici V, Sartori A, Rasia S, Cordioli C, Di Sapio A, Pontecorvo S, Grasso R, Barrilà C, Russo CV, Esposito S, Ippolito D, Bovis F, Gallo F, Sormani MP.

Mult Scler. 2019 Aug;25(9):1263-1272. doi: 10.1177/1352458518790390. Epub 2018 Jul 25.

PMID:
30044207
41.

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.

Pane M, Coratti G, Brogna C, Mazzone ES, Mayhew A, Fanelli L, Messina S, D'Amico A, Catteruccia M, Scutifero M, Frosini S, Lanzillotta V, Colia G, Cavallaro F, Rolle E, De Sanctis R, Forcina N, Petillo R, Barp A, Gardani A, Pini A, Monaco G, D'Angelo MG, Zanin R, Vita GL, Bruno C, Mongini T, Ricci F, Pegoraro E, Bello L, Berardinelli A, Battini R, Sansone V, Albamonte E, Baranello G, Bertini E, Politano L, Sormani MP, Mercuri E.

PLoS One. 2018 Jun 20;13(6):e0199223. doi: 10.1371/journal.pone.0199223. eCollection 2018.

42.

Clinical activity after fingolimod cessation: disease reactivation or rebound?

Frau J, Sormani MP, Signori A, Realmuto S, Baroncini D, Annovazzi P, Signoriello E, Maniscalco GT, La Gioia S, Cordioli C, Frigeni B, Rasia S, Fenu G, Grasso R, Sartori A, Lanzillo R, Stromillo ML, Rossi S, Forci B, Cocco E; i-MuST study group.

Eur J Neurol. 2018 Oct;25(10):1270-1275. doi: 10.1111/ene.13694. Epub 2018 Jul 10.

PMID:
29851435
43.

Cerebrospinal fluid shunt-associated infections in pediatrics: Analysis of the epidemiology and mortality risk factors.

González S, Carbonaro M, Fedullo AG, Sormani MI, Ceinos MDC, González R, Rosanova MT.

Arch Argent Pediatr. 2018 Jun 1;116(3):198-203. doi: 10.5546/aap.2018.eng.198. English, Spanish.

44.

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, Wolinsky JS.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):346-356. doi: 10.1002/acn3.534. eCollection 2018 Mar.

45.

Osteoarticular infections in a tertiary care children's hospital: Epidemiology and clinical characteristics in association with bacteremia.

Highton E, Pérez MG, Cedillo Villamagua C, Sormani MI, Mussini MS, Isasmendi A, Pinheiró J, Reijtman V, Taicz M, Mastroianni A, García ME, Rosanova MT.

Arch Argent Pediatr. 2018 Apr 1;116(2):e204-e209. doi: 10.5546/aap.2018.eng.e204. English, Spanish.

46.

Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.

Opfer R, Ostwaldt AC, Walker-Egger C, Manogaran P, Sormani MP, De Stefano N, Schippling S.

J Neurol. 2018 May;265(5):1158-1165. doi: 10.1007/s00415-018-8825-8. Epub 2018 Mar 16.

PMID:
29549466
47.

Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults.

Opfer R, Ostwaldt AC, Sormani MP, Gocke C, Walker-Egger C, Manogaran P, De Stefano N, Schippling S.

Neurobiol Aging. 2018 May;65:1-6. doi: 10.1016/j.neurobiolaging.2017.12.024. Epub 2017 Dec 30.

PMID:
29407463
48.

Cognitive clinico-radiological paradox in early stages of multiple sclerosis.

Uher T, Krasensky J, Sobisek L, Blahova Dusankova J, Seidl Z, Kubala Havrdova E, Sormani MP, Horakova D, Kalincik T, Vaneckova M.

Ann Clin Transl Neurol. 2017 Dec 15;5(1):81-91. doi: 10.1002/acn3.512. eCollection 2018 Jan.

49.

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20. Erratum in: Mult Scler. 2020 Feb 4;:1352458520906383.

PMID:
29353550
50.

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Erratum in: Eur J Neurol. 2018 Mar;25(3):605.

PMID:
29352526

Supplemental Content

Loading ...
Support Center